Skip to main content
Clinical Trials/JPRN-UMIN000037433
JPRN-UMIN000037433
Completed
未知

An observational study of symptomatic adverse events and health-related quality of life (HR-QoL) with the use of patient-reported outcome (PRO) in nivolumab therapy for gastric cancer - NIVO-G QoL Study

St.Marianna University School of Medicine0 sites30 target enrollmentJuly 20, 2019
Conditionsgastric cancer

Overview

Phase
未知
Intervention
Not specified
Conditions
gastric cancer
Sponsor
St.Marianna University School of Medicine
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2019
End Date
January 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Major Exclusion Criteria: 1\.Patients who meet any of the following exclusion criteria will be excluded from this study: 2\.Patients who concurrently participate in another detailed PRO study. 3\.Patients who apparently have difficulty in evaluating their symptoms by themselves due to a mental condition or cognitive impairment. 4\.Patients who apparently have difficulty in using an electronic device for data entry due to a physical disability

Outcomes

Primary Outcomes

Not specified

Similar Trials